Stocktoria
Coherus Oncology, Inc. CHRS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-11-06
Coherus Oncology, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Satvat Ali J. | director | 2026-06-05 | Grant | 30,000 | — |
| Karachun Rita A | director | 2026-06-05 | Grant | 30,000 | — |
| Newcomer Lee Nisley | director | 2026-06-05 | Grant | 30,000 | — |
| Ryan Michael Lee | director | 2026-06-05 | Grant | 30,000 | — |
| O'Donnell-Tormey Jill | director | 2026-06-05 | Grant | 30,000 | — |
| Wahlstrom Mats | director | 2026-06-05 | Grant | 30,000 | — |
| Newton Charles W. | director | 2026-06-05 | Grant | 30,000 | — |
| Lanfear Dennis M | President & CEO | 2026-01-23 | Grant | 375,000 | — |
Source: SEC EDGAR filings · CIK 0001512762 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.